BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14666966)

  • 21. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
    Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
    Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival.
    Arriaga JM; Levy EM; Bravo AI; Bayo SM; Amat M; Aris M; Hannois A; Bruno L; Roberti MP; Loria FS; Pairola A; Huertas E; Mordoh J; Bianchini M
    Hum Pathol; 2012 Feb; 43(2):197-208. PubMed ID: 21820154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of functional prolactin and its receptor in human colorectal cancer.
    Otte JM; Otte C; Beckedorf S; Schmitz F; Vonderhaar BK; Fölsch UR; Kloehn S; Herzig KH; Mönig H
    Int J Colorectal Dis; 2003 Jan; 18(1):86-94. PubMed ID: 12458387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
    Zhang N; Ding YQ; Liang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance.
    Zhang Z; Wang Q; Li P; Zhou Y; Li S; Yi W; Chen A; Kong P; Hu C
    Cancer Epidemiol; 2009 Aug; 33(2):130-6. PubMed ID: 19679060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
    Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
    J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of phospholipase D2 in human colorectal carcinoma.
    Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
    Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.